Development of a New TROP-2 ADC with Better Therapeutic Window

Time: 10:10 am
day: Day One

Details:

• TROP has emerged as an appealing target for ADC development
• Tackling the unique challenge for a target with larger tissue distribution and utilization of weaker payload
• Witnessing how novel ADC design has achieved better linker stability, which has greatly reduced ADC toxicity and improved therapeutic window

Speakers:

Hui Lu From 2010 to 2015, he served as an Executive Director of Business Development at PPD/BioDuro, where he was responsible from business strategy formulation to collaboration Read more